Connect with us

Subscribe

Cancer

90Y-ibritumomab tiuxetan

A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 90Y-Zevalin, IDEC-Y2B8, and yttrium Y 90-ibritumomab tiuxetan.

Source: NCI Dictionary of Cancer Terms

Search the Glossary of Medical Terms

90Y-DOTA-biotin
90Y-Zevalin
Newsletter

Sign up for the QuackTrack.org newsletter below!

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

QuackTrack on Twitter

Trending Posts

Connect
Newsletter

Sign up for the QuackTrack.org newsletter below!